The PD-1-PD-L pathway in immunological tolerance (Q36405777)

scientific article

Language	Label	Description	Also known as
English	The PD-1-PD-L pathway in immunological tolerance	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

title

The PD-1-PD-L pathway in immunological tolerance (English)

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

2

Tasuku Honjo

0 references

author name string

Taku Okazaki

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

16500147

retrieved

14 August 2017

language of work or name

1 reference

24 February 2006

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

27

1 reference

stated in

Europe PubMed Central

14 August 2017

195-201

1 reference

stated in

Europe PubMed Central

14 August 2017

4

1 reference

stated in

Europe PubMed Central

14 August 2017

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/J.1460-2075.1992.TB05481.X

Expression of programmed death 1 ligands by murine T cells and APC

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4049/JIMMUNOL.169.10.5538

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

A critical role for the programmed death ligand 1 in fetomaternal tolerance

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Association of PDCD1 with susceptibility to systemic lupus erythematosus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

The B7 family revisited

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Differential binding properties of B7-H1 and B7-DC to programmed death-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

New regulatory co-receptors: inducible co-stimulator and PD-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7 family molecules are favorably positioned at the human maternal-fetal interface

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Fc receptors and their role in immune regulation and autoimmunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Tolerogenic dendritic cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

The roles of the new negative T cell costimulatory pathways in regulating autoimmunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Designer dendritic cells for tolerance induction: guided not misguided missiles

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-1 inhibits antiviral immunity at the effector phase in the liver

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.IT.2006.02.001

Identifiers

DOI

10.1016/J.IT.2006.02.001

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

PubMed ID

16500147

retrieved

14 August 2017

The PD-1-PD-L pathway in immunological tolerance (Q36405777)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

The PD-1-PD-L pathway in immunological tolerance (Q36405777)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search